The future of canine parvovirus treatment

home / pet-connections / the-future-of-canine-parvovirus-treatment

Join our panel of experts as they share their insights and experiences with canine parvovirus, and learn how monoclonal antibody therapy may improve survival and recovery outcomes

Meet the canine parvovirus panel

EP. 1: Meet the canine parvovirus panel

Bob Alaburda, Associate Editorial Director
October 12th 2023

The panel shares their credentials and breadth of expertise

Watch

How Parvo is wreaking havoc on the pet community

EP. 2: How Parvo is wreaking havoc on the pet community

Bob Alaburda, Associate Editorial Director
October 12th 2023

Our panel weighs in on the heavy toll of this devastating disease

Watch

COVID-19's impact on Parvo management

EP. 3: COVID-19's impact on Parvo management

Bob Alaburda, Associate Editorial Director
October 19th 2023

Panelists discuss how Parvo management changed during the COVID-19 pandemic

Watch

The learning process while managing Parvo

EP. 4: The learning process while managing Parvo

Bob Alaburda, Associate Editorial Director
October 19th 2023

How Parvo affects the human/animal bond

Watch

Parvo and hospital morale

EP. 5: Parvo and hospital morale

Bob Alaburda, Associate Editorial Director
October 26th 2023

Panelists discuss how to boost hospital morale while managing Parvo cases

Watch

Socialization for puppies affected by Parvo

EP. 6: Socialization for puppies affected by Parvo

Bob Alaburda, Associate Editorial Director
October 26th 2023

The panel explains how Parvo affects early development for puppies and shares advice for pet parents

Watch

The new canine Parvovirus monoclonal antibody

EP. 7: The new canine Parvovirus monoclonal antibody

Bob Alaburda, Associate Editorial Director
November 2nd 2023

Panelists share their excitement regarding the new canine Parvovirus monoclonal antibody

Watch

Comparing CPMA with previous treatment options

EP. 8: Comparing CPMA with previous treatment options

Bob Alaburda, Associate Editorial Director
November 2nd 2023

How CPMA works and how it differs from pre-existing treatment options

Watch

Contraindications to consider during treatment

EP. 9: Contraindications to consider during treatment

Bob Alaburda, Associate Editorial Director
November 9th 2023

Contraindications and things to look out for while using CPMA for treatment

Watch

Optimizing the use of CPMA to best treat patients

EP. 10: Optimizing the use of CPMA to best treat patients

Bob Alaburda, Associate Editorial Director
November 9th 2023

Panelists share their experiences with using CPMA for Parvo treatment

Watch

How CPMA affects survivability

EP. 11: How CPMA affects survivability

Bob Alaburda, Associate Editorial Director
November 16th 2023

The panel discusses how CPMA impacts survivability, hospital morale, and the human/animal bond

Watch

Limitations during Parvo treatment

EP. 12: Limitations during Parvo treatment

Bob Alaburda, Associate Editorial Director
November 16th 2023

How cost, accessibility, and patient condition affect treatment

Watch

Looking into the future of Parvo treatment

EP. 13: Looking into the future of Parvo treatment

Bob Alaburda, Associate Editorial Director
November 30th 2023

How monoclonal antibodies like CPMA can help change the future of veterinary medicine

Watch

© 2024 MJH Life Sciences

All rights reserved.